Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
Innovations in Clinical Neuroscience|February 8, 2018
Negative Symptom Dimensions of the Positive and Negative Syndrome Scale Across Geographical Regions: Implications for Social, Linguistic, and Cultural ConsistencyAnzalee Khan, Lora Liharska, Philip D Harvey, et al.Journal of Clinical Psychopharmacology|January 2, 2013
Assessing the sources of unreliability (rater, subject, time-point) in a failed clinical trial using items of the Positive and Negative Syndrome Scale (PANSS)Anzalee Khan, William Christian Yavorsky, Stacy Liechti, et al.Clinical Schizophrenia & Related Psychoses|December 21, 2011
Ziprasidone's effect on metabolic markers in patients with diabetes and chronic schizophreniaJean Pierre Lindenmayer, Frank Tedeschi, Anna Yusim, et al.Schizophrenia Research|August 11, 2015
COMT genotype and response to cognitive remediation in schizophreniaJean-Pierre Lindenmayer, Anzalee Khan, Herbert Lachman, et al.Patient Preference and Adherence|February 6, 2020
Patient Perspective in the Development of Electronic Patient-Reported Outcomes (ePROs) in Seizure Disorders: A Patient-Centric ApproachAnzalee Khan, Alyssa Peechatka, Nadeeka R Dias, et al.Psychopathology|May 18, 2017
Validation of the Five-Factor Model of the Arabic Version of the Positive and Negative Syndrome Scale in SchizophreniaArij Yehya, Suhaila Ghuloum, Ziyad Mahfoud, et al.Brain Stimulation|October 15, 2018
Transcranial direct-current stimulation in ultra-treatment-resistant schizophreniaJ P Lindenmayer, Mila Kirstie C Kulsa, Tania Sultana, et al.Schizophrenia Research|January 18, 2017
The relationship of cognitive improvement after cognitive remediation with social functioning in patients with schizophrenia and severe cognitive deficitsJ P Lindenmayer, Samantha Fregenti, Guoxin Kang, et al.The Journal of Clinical Psychiatry|June 7, 2018
Cognitive Effects of MIN-101 in Patients With Schizophrenia and Negative Symptoms: Results From a Randomized Controlled TrialRichard S E Keefe, Philip D Harvey, Anzalee Khan, et al.Schizophrenia Research|May 28, 2026
Psychometric analysis of speech-based digital biomarkers of alogia symptoms in treatment resistant schizophrenia: Comparison with clinical ratings of expressive negative symptomsJean-Pierre Lindenmayer, Anzalee Khan, Beverly J Insel, et al.Pageof 5